Get the Daily Brief
Latest Biotech News
Nutritional and Agricultural Innovations and Challenges
Physicians advocate for prioritizing legumes as key protein food sources in upcoming US dietary guidelines, underscoring their nutritional benefits. Studies reveal irrigation's dual impact on...
AI Transforms Cancer Characterization and Therapeutic Discovery
A multinational consortium led by the Garvan Institute of Medical Research has introduced AAnet, an advanced AI-driven framework designed to delineate cellular heterogeneity within tumors with...
Revolution Medicines Secures $2 Billion Royalty Deal to Advance RAS Inhibitors
Revolution Medicines has secured up to $2 billion from Royalty Pharma through a flexible funding agreement consisting of $1.25 billion in synthetic royalties and $750 million in corporate debt....
Nektar Therapeutics’ Rezpegaldesleukin Shows Promise in Atopic Dermatitis Amid Market Dynamics
At the Society of Nuclear Medicine and Molecular Imaging 2025 meeting, Nektar Therapeutics presented compelling Phase 2b data demonstrating rezpegaldesleukin’s efficacy in treating moderate to...
Mitochondrial Base Editing Breakthrough Offers Hope for Genetic Disease Treatment
Researchers at the University Medical Center Utrecht and collaborators report successful mitochondrial base editing to correct pathogenic mutations in mitochondrial DNA using a...
AI Innovations Expand in Health Tech and Genomic Research
City of Hope has developed and fine-tuned HopeLLM, a generative AI platform leveraging extensive oncology datasets to streamline new patient onboarding, personalize clinical trial matching, and...
Novel Biomaterials and Technologies Address Medical and Environmental Challenges
Innovations span from Texas A&M’s synthetic lichens enabling autonomous construction on Mars using local regolith, to a Korea-developed β2 adrenergic agonist drug activating muscle metabolism as a...
Breakthroughs in Cancer Diagnostics and Therapeutics
Significant strides in cancer care include the Association for Molecular Pathology’s new best practice guidelines standardizing homologous recombination deficiency testing, enhancing diagnostic...
Regulatory and Industry Leadership Developments Shape Biotech Landscape
The FDA faces notable leadership turnover including the scheduled retirement of Jacqueline Corrigan-Curay, acting head of the Center for Drug Evaluation and Research, amid broader agency...
Emerging Technologies in AI and Machine Learning for Healthcare and Materials Science
Artificial intelligence continues to accelerate innovation across biotech and materials science. A University of Gothenburg doctoral thesis reveals AI methodologies that enhance woven composite...
Major Advances in Biotech Financing and Market Movements
Multiple biotech companies secured significant financing and experienced notable market activity. Jyong Biotech raised $20 million in a Nasdaq IPO to support urological botanical drugs...
Nektar Therapeutics’ Rezpegaldesleukin Shows Promise in Eczema Trials
Nektar Therapeutics reported positive Phase 2b results for rezpegaldesleukin (rezpeg) in treating atopic dermatitis, marking a significant clinical milestone for the biologic drug. The drug...
Illumina’s Acquisition of SomaLogic Advances Multiomics Strategy
Illumina announced a definitive agreement to acquire SomaLogic for up to $425 million, strategically enhancing its proteomics capabilities and bolstering its multiomics portfolio. This transaction...
Cidara Therapeutics’ Flu Prevention Biologic Shows Strong Phase 2b Results
Cidara Therapeutics’ long-acting antiviral biologic, CD-388, demonstrated robust efficacy in preventing seasonal influenza in healthy adults aged 18 to 64 in a randomized, placebo-controlled Phase...
Novo Nordisk Ends Partnership with Hims Over Compounded Obesity Drugs
Novo Nordisk terminated its marketing collaboration with Hims & Hers for the obesity drug Wegovy, accusing Hims of illegal mass compounding of the drug following the official end of a shortage...
Advanced AI Tools Aid Cancer Characterization and Treatment Precision
A multinational research collaboration including the Garvan Institute of Medical Research unveiled AAnet, an artificial intelligence tool designed to analyze cellular heterogeneity within tumors...
Breakthroughs in Gene Editing Target Mitochondrial Mutations
Scientists in the Netherlands achieved a significant milestone by utilizing mitochondrial base editing to directly correct deleterious mutations in human cells. Using a double-stranded DNA...
City of Hope Unveils Generative AI Platform for Cancer Care Enhancement
City of Hope launched HopeLLM, a proprietary generative AI platform that integrates multiple commercial and open-source models with the center’s extensive oncology data. HopeLLM automates...
New Cancer Therapeutics Emerge from Gene Regulation Research
University of Geneva researchers identified two key proteins involved in the chromatin remodeling process that regulates gene accessibility, which is crucial for controlled gene expression....
Revolution Medicines Secures $2 Billion Deal to Fund RAS Inhibitor Development
Revolution Medicines finalized a major financing agreement with Royalty Pharma, obtaining up to $2 billion in committed capital to support late-stage development and commercialization of its...